What Happens If Wegovy Is Not Refrigerated

Semaglutide is a protein-based medicine that degrades when exposed to heat, freezing, or prolonged time outside the fridge — visible changes are not always a reliable warning sign.
Wegovy pens have an approved room-temperature window; once that window closes, the pen should not be used, even if the liquid looks normal.
Freezing a Wegovy pen is just as damaging as overheating, a pen that has been frozen must be discarded, regardless of how it looks afterwards.
Your prescriber or pharmacist is the right person to advise whether a pen that has been left out can still be used, this is not a decision to make alone.

If Wegovy is not refrigerated, the semaglutide inside the pen can degrade. Protein-based medicines like semaglutide are sensitive to temperature, and exposure to heat above the permitted room-temperature limit reduces potency over time. That said, Wegovy is approved for a short period at room temperature — the precise window is stated in the Patient Information Leaflet and the Wegovy SmPC on the eMC, and it is that document, not general guidance, that governs your specific pen. What this page covers is what we know about degradation, how to tell whether a pen has been compromised, and what to do next.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How temperature affects your Wegovy pen, step by step

Step 1, Understanding why temperature matters for semaglutide

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist made from a modified protein structure. Like all protein-based medicines, it relies on that structure remaining intact to bind correctly to its target receptors in the body. Heat disrupts that structure through a process called denaturation: the protein folds in on itself incorrectly, losing its ability to work as intended. The NHS medicines information for semaglutide confirms that Wegovy pens must be stored in a refrigerator at 2°C to 8°C before first use.

One misconception worth clearing up: a pen that has been left out does not necessarily look different. The liquid may remain clear, colourless, and free of particles, yet still contain degraded medicine. Visual inspection alone is not a safe way to decide whether a pen is still suitable. This catches people out regularly, the pen looks fine, so they assume it is fine. That assumption is not reliable for a protein-based injectable.

It is also worth knowing that cold is not automatically safer than warmth. A pen exposed to freezing temperatures (left in a car overnight in winter, or accidentally placed against the back wall of a fridge where it froze) is also unsuitable for use. Freezing causes ice crystals to form within the solution, physically disrupting the protein. A pen that has frozen must be discarded, full stop. You can read more about the broader storage requirements on our Wegovy refrigeration guide.

Step 2, The approved room-temperature window and what happens when it passes

Wegovy is not strictly a medicine that must live in the fridge every moment before it is used. Novo Nordisk and regulators recognise that people travel, carry pens to work, and sometimes forget to return a pen to the fridge. For this reason, the SmPC and Patient Information Leaflet include an approved period during which a pen may be kept at room temperature, below a defined maximum temperature, after which it must either be used or discarded.

The exact duration and temperature ceiling are specified in the leaflet that comes with your pen, and those figures should be treated as binding. Our page on whether you can use Wegovy left at room temperature goes into the practical questions around this in more detail. The key point here is that once the approved window closes, the pen should not be returned to the fridge and used later as though the clock reset. It cannot. The window is cumulative: time spent at room temperature across multiple occasions counts together.

Beyond that window, the medicine's potency is no longer guaranteed. Using a degraded pen does not mean you will be harmed in the way a counterfeit product might harm you, but it does mean you may be injecting less active medicine than the dose printed on the pen, which undermines the purpose of treatment. If you are unsure whether your pen is still within its approved period, our guide on whether Wegovy goes bad outside the fridge covers the specifics. The same question comes up frequently for semaglutide in other forms, and our guide on whether semaglutide can be used if it has not been refrigerated addresses those concerns in detail.

Step 3, What to do if your Wegovy was not refrigerated properly

First, check your Patient Information Leaflet. The leaflet shipped with every Wegovy pen states the room-temperature storage window clearly. If you know roughly how long the pen was out and the conditions it was in, you can compare that against the approved limit. If you are within it, the pen is generally considered suitable for use, but if you have any doubt, contact your pharmacist or prescriber before injecting.

If you believe the pen has been outside approved conditions for longer than permitted, do not use it. Contact your prescriber or pharmacist to explain what happened. In many cases a replacement can be arranged, and your clinical team can confirm the right next step for your dosing schedule. This is particularly important if you are mid-titration, since a missed dose at the wrong stage can affect how your body responds to the next step. Our page for people whose Wegovy was not refrigerated correctly covers the replacement process in more practical terms.

Disposing of a pen you cannot use: remove the needle carefully and place the pen and needle in an appropriate sharps container before disposal. Do not put used or damaged pens in household waste. Your pharmacist can advise on your local disposal route.

For anyone considering starting treatment, or reviewing whether Wegovy is the right option, our weight-loss treatment overview explains what is licensed and how clinical assessment works in a private setting. Wegovy is a prescription-only medicine and always requires a prescriber's involvement, not just at the first prescription, but at each review. The NHS patient information for semaglutide, available via the NHS medicines library, is also a reliable reference for storage and side-effect questions.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions